A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

Sana Biotechnology manoeuvres from Harvard Sana has emerged with funding from investors including F-Prime Capital, Arch and Flagship Pioneering to develop genetically modified hypoimmogenic stem cells. Strathclyde fuels industrial biotech proposal An industrial biotech initiative co-led by University of Strathclyde has received UK government funding to prepare an application to the UKRI’s competitive Strength in Places program. Starts at 60 relishes $1.9m QUT Bluebox has joined corporates Holland Insurance and Seven West Media in the second funding round for over-60s package holiday portal Starts at 60. Saarland takes its incubator nationwide IT Inkubator at University of Saarland will open its program to researchers across Germany, who will however have to join the existing facilities in Saarbrücken. Vivlion comes into view Goethe University Frankfurt has spun out Vivlion to commercialise a library of the human genome that could drive the development of more Crispr therapies. Bahns nudges across to WaveOptics Robert Bahns has stepped down as technology partner at IP Group to become chief financial officer at one of the firm’s portfolio businesses, WaveOptics. Harvard harvests $150m for buyout fund The university has reportedly backed an oversubscribed $1.5bn buyout vehicle launched by Arcline aiming to take over eight-to-10 mid-market companies. Liftupp climbs with ExamSoft Liverpool’s health sciences academic assessment software spinout has been bought by exam platform ExamSoft, which will augment and integrate its services. Inivata invites investors to series B IP Group, CIC and Johnson & Johnson have returned for a $52.2m series B round in Inivata, a spinout of Cancer Research UK and University of Cambridge. Elicio elicits $30m Building on work at MIT’s Koch Institute of Integrative Cancer Research, Elicio hopes to begin patient studies in 2020 for pancreatic, colorectal, head and neck cancers. Inivata invites investors to series B IP Group, CIC and Johnson & Johnson have returned for a $52.2m series B round in Inivata, a spinout of Cancer Research UK and University of Cambridge. Cytena cites $3.4m HTGF has returned to back Freiburg’s single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015. AMOpportunities places $2.2m Chicago’s endowment participated in the series A, following a $1.1m seed round last year that included prize money from the Chicago-run New Venture Challenge. GeoSpock locates additional capital Parkwalk Advisors has injected an additional $2.6m into GeoSpock, two months after the Cambridge spinout secured $12.8m in a round co-led by the fund manager. Cambridge Enterprise refreshes board The office has appointed three directors and two…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?